Glucosamine Sulfate 500 mg + Chondoitin 250 mg
Glucosamine Sulfate 500 mg + Chondoitin 250 mg, NPN 80021592: natural health product licensed in Canada. Medicinal ingredients: Sulfate de glucosamine, Sulfate de chondroïtine.
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Sulfate de glucosamine Source : Sulfate de glucosamine 2KCl provenant d'exosquelettes de crevette, crabe et/ou homard | 500 mg | Not calculated |
| Sulfate de chondroïtine Source : Calf trachea | 250 mg | Not calculated |
Non-medicinal ingredients
Eau, Gélatine, Stéarate de magnésium
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1 Capsule | 3 Tous les jours |
Uses authorised in Canada
Helps to relieve joint pain associated with osteoarthritis.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Cautions and Warnings
Consult a health care practitioner if symptoms worsen. For prolonged use, consult a health care practitioner. Consult a health care practtioner if you experience gastroointestinal pain or bowel movement disturbances. Discontinue use if allergic reaction occus.
- Contra-Indications
Do not use if you are pregnant or breastfeeding.
Product record
- Licence holder
- Prime Health Ltd. (Canada Global Life Sciences)
- NPN or DIN-HM
- 80021592
- Status
- Active licence
- Licence date
- 4 October 2010
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
Source
Official Health Canada record, licence 80021592
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.
Cite this page: CompoAtlas, “Glucosamine Sulfate 500 mg + Chondoitin 250 mg (Prime Health Ltd. (Canada Global Life Sciences)): composition and ingredients”, https://compoatlas.com/en/supplements/canada/80021592-glucosamine-sulfate-500-mg-chondoitin-250-mg, updated 4 October 2010.